Biotech Biocom

Embed Size (px)

Citation preview

  • 8/17/2019 Biotech Biocom

    1/12

    Executive summA comprehensive approach to scientifc deve

  • 8/17/2019 Biotech Biocom

    2/12

    Summary : Objective: What? Why? Who? Ho

    Where?

    iotech aja

     !o brin" to the state o#$ali#ornia %exico the rand development operthe $ali#ornia &S iote'ndustry( providin" a c

    savin" and e)ective oin#rastructure to all intparties in order to maicompetitiveness with ocountries outside *A+!

  • 8/17/2019 Biotech Biocom

    3/12

    WHATIS BIOTECHNOLOGY?

    -ru"./harm0 123

    -istrib io0 123

    -evic E4uip0 563

    7 an - 8ab0 93

    Bio TechCalifornia USA

    26 Billion !he biotechnolo"y sector isbest understood as a "roup

    o# diverse industries with acommon lin; < theapplication o# biolo"icalscientifc ;nowled"e,

    iotechnolo"y harnessescellular and bio molecular

    processes to developtechnolo"ies and products

    that combat debilitatin" and

    rare diseases( reduce ourenvironmental #ootprint( #eedthe hun"ry( use less and

    cleaner ener"y( and havesa#er( cleaner and more

    e=cient industrialmanu#acturin" processes,

  • 8/17/2019 Biotech Biocom

    4/12

    io !echeach

     !he strate"ic our re"ion playour businesscenter o# a coe)ective hi"hmar;et scenahave in %exichi"h 4uality oand low cost

    capabilities wthe same a mdrive to one omost technoloinuential andeconomically states in Ame

  • 8/17/2019 Biotech Biocom

    5/12

    iotech companies in San -ie"o @!op 1Acadia /harmaceuticals

    5Accelovance

    6Accumetrics

    9A$O* 8aboratories

    2A-CE*!7D /harmaceuticals

    A"ilent !echnolo"ies

    AlereFAllermed 8aboratories

    GAlliance /harmaceutical

    1Allylix

    11Althea !echnolo"ies

    15Ambit iosciences

    16Amira /harmaceuticals

    19Amylin /harmaceuticals

    12Anadys /harmaceuticals

    1Anaptysio

    1Apricus iosciences

    1FAptiv Solutions

    1GA4uaounty !echnolo"ies

    5Ardea iosciences

    51Arena /harmaceuticals

    55AC'CA iosciences

    56ecton -ic;inson

    59ioAtla

    52iocept

    5io%edica

    5io"en 'dec

    5Fiosite -ia"nostics

    5GioSurplus

    6rain$ells

    61$adence /harmaceuticals

    65$almune

    66$arolus !herapeutics

    69$ato 7esearch

    62$el"ene

    6$ere"ene

    6$harles 7iver 8aboratories

    6F$hem-iv

    6G$linimetrics

    9$onatus /harmaceuticals91$ypress ioscience

    95$ytori !herapeutics

    96eioscience

    99E%- $hemicals

    92Exelixis

    9en./robe

    9enomatica

    9FenIyme

    9GHaloIyme !herapeutics

    2Harbor ioSciences

    21Helicon !herapeutics

    25Hospira

    26H&JA ioscience 'nternational

    29'ASO /harma

    22'chor %edical Systems

    2'llumina

    2'*$ 7esearch

    2F'novio iomedical $orporation

    2Gi!herD

    8i"and /harmaceuticals

    1%abCax !herapeutics

    5%arshall Edwards

    6%edici*ova

    9%icro$onstants

    2%ixture Sciences

    %ultiE* -ia"nostics

    *eurocrine iosciences

    F*uCasive

    GOcera !herapeutics

    Optimer /harmaceuticals

    1/acira /harmaceuticals

    5/A7EDE8 'nternational

    6/erceptive 'n#ormatics

    9/harma*et -evelopment roup

    2//-

    /7A 'nternational

    /rometheus 8aboratories

    FKuidel

    GKuintiles

    F7es%ed

    F17ECA %edical

    F5Santarus

    F6Senomyx

    F9Se4uel /harmaceuticals

    F2Se4uenom

    FS7'

    FStrate"ic EnIyme Applications

    FFSynbiotics

    FG!racon /harmaceuticalsG!ra"ara /harmaceuticals

    G1!rius !herapeutics

    G5Centi7x /harmaceuticals

    G6Cerenium

    G9Certex /harmaceuticals

    G2Cical

    GColcano $orporation

    GLacharon /harmaceuticals

    GFLo"enix

  • 8/17/2019 Biotech Biocom

    6/12

    $ompetitiveness

  • 8/17/2019 Biotech Biocom

    7/12

    $ompetitiveness

     Mapan iotech11 billion

  • 8/17/2019 Biotech Biocom

    8/12

    ServicesScientifc

    andtechnolo"y solutions

    8coSharedservices

    Our comprehensive approach

    serves 6 main areasN  Scientifc and technolo"y

    solutions, Our members havetop credentials andexperience in their felds,

      Shared services, $oste)ective state o# the artinstallations,

     

    8e"al and commercial,+rom establishin" the 7 ad -operations to licensin"products( commercial useauthoriIation and productmanu#acturin" andcommercialiIation,

  • 8/17/2019 Biotech Biocom

    9/12

    Advanta"esOr e!cellen" s"an#in$ rela"ion %i"h $overn&re$la"or' o(cials an# s)eciall' *e!ico+s CO%hich is "he e!ac" e/ivalen" of "he A&erica

    s "o han#le or inves"i$a"ion an# )ro"ocola"hori1a"ions in a 3"h of "he "i&e i" %ol# US5

    0a"a collec"e# in so&e cases can e in"ro#cea))rove# "rials5 This allo%s a shor"er "i&e forclinical "rials5

  • 8/17/2019 Biotech Biocom

    10/12

    Advanta"es !he !echnolo"y &niversity o# !ijuana aAutonomous &niversity o# aja $ali#orinternationally reco"niIed #aculties o#

    aerospace( medicine( biotech( mechatseveral other technolo"ical sciences, de 8as /almas,

  • 8/17/2019 Biotech Biocom

    11/12

    7ELO.$onservation

    .*IStem cells I&&ne ET

    /harmaceuticals

    *'oS"e&%edical devices

  • 8/17/2019 Biotech Biocom

    12/12!han; Jou